James Thommes
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Hepatology 16
- Hepatitis C virus research 16
- Oncology 6
- Viral-associated cancers and disorders 4
- Co-authors
- Richard D. Mamelok (2 shared papers)Bruce J. Dezube (2 shared papers)Donald W. Northfelt (2 shared papers)Margaret A. Fischl (1 shared paper)Bárbara Miller (1 shared paper)Charles Du Mond (1 shared paper)Alvin E. Friedman‐Kien (1 shared paper)David H. Henry (1 shared paper)
- Journals
- Journal of Hepatology (9 papers)Gastroenterology (3 papers)Antiviral Therapy (2 papers)Hepatology (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
James Thommes
32 papers receiving 1.0k citations
James Thommes's Hit Papers
Peers
Comparison fields: 5 of 83
- Hepatology 222
- Biomaterials 222
- Oncology 370
- Virology 63
- Pathology and Forensic Medicine 140
Countries citing papers authored by James Thommes
This map shows the geographic impact of James Thommes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Thommes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Thommes more than expected).
Fields of papers citing papers by James Thommes
This network shows the impact of papers produced by James Thommes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Thommes. The network helps show where James Thommes may publish in the future.
Co-authors
The 25 scholars most cited alongside James Thommes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. Hit paper breakdown → | 1998 | 522 |
| 2 | 1997 | 143 | |
| 3 | 1992 | 66 | |
| 4 | 2013 | 45 | |
| 5 | 2003 | 41 | |
| 6 | 2013 | 38 | |
| 7 | 2011 | 38 | |
| 8 | 2010 | 37 | |
| 9 | 2010 | 25 | |
| 10 | 2007 | 21 | |
| 11 | 1980 | 21 | |
| 12 | 2007 | 14 | |
| 13 | 2010 | 14 | |
| 14 | 2012 | 12 | |
| 15 | 2012 | 12 | |
| 16 | 2008 | 7 | |
| 17 | 1998 | 7 | |
| 18 | 2016 | 6 | |
| 19 | 2017 | 6 | |
| 20 | 2016 | 6 |
About James Thommes
James Thommes is a scholar working on Hepatology, Oncology, Pathology and Forensic Medicine, Epidemiology and Rheumatology, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (16 papers), Systemic Lupus Erythematosus Research (5 papers), Viral-associated cancers and disorders (4 papers), HIV/AIDS drug development and treatment (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Microscopic Colitis (3 papers). The work is most often cited by research in Hepatology (222 citations), Biomaterials (222 citations), Oncology (370 citations), Virology (63 citations) and Pathology and Forensic Medicine (140 citations). James Thommes has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Richard D. Mamelok, Bruce J. Dezube, Donald W. Northfelt, Margaret A. Fischl, Bárbara Miller, Charles Du Mond, Alvin E. Friedman‐Kien, David H. Henry, Lawrence D. Kaplan and Jamie H. Von Roenn. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Antiviral Therapy, Hepatology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.